| Nome do produto |
neuromedina B |
| Sinônimos |
H-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2; (2S)-2-[(2-aminoacetil)amino]-N-[(1S)-1-[[(1S)-2-[[(1S)-2-[[(1S,2R)-1-[[2-[[(1S)-2-[[1-benzil-2-[[(1S)-1-carbamoil-3-metilsulfanil-propil]amino]-2-oxo-etil]amino]-1-(3H-imidazol-4-ilmetil)-2-oxo-etil]amino]-2-oxo-etil]carbamoil]-2-hidroxi-propil]amino]-1-metil-2-oxo-etil]amino]-1-(1H-indol-3-ilmetil)-2-oxo-etil]carbamoil]-3-metil-butil]butanodiamida |
| Nome em inglês |
neuromedin B; H-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2; (2S)-2-[(2-aminoacetyl)amino]-N-[(1S)-1-[[(1S)-2-[[(1S)-2-[[(1S,2R)-1-[[2-[[(1S)-2-[[1-benzyl-2-[[(1S)-1-carbamoyl-3-methylsulfanyl-propyl]amino]-2-oxo-ethyl]amino]-1-(3H-imidazol-4-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]amino]-1-methyl-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-methyl-butyl]butanediamide |
| Fórmula molecular |
C52H73N15O12S |
| Peso Molecular |
1132.2943 |
| InChI |
InChI=1/C52H73N15O12S/c1-27(2)17-36(64-51(78)40(21-41(54)69)61-42(70)22-53)48(75)66-38(19-31-23-57-34-14-10-9-13-33(31)34)47(74)60-28(3)46(73)67-44(29(4)68)52(79)58-25-43(71)62-39(20-32-24-56-26-59-32)50(77)65-37(18-30-11-7-6-8-12-30)49(76)63-35(45(55)72)15-16-80-5/h6-14,23-24,26-29,35-40,44,57,68H,15-22,25,53H2,1-5H3,(H2,54,69)(H2,55,72)(H,56,59)(H,58,79)(H,60,74)(H,61,70)(H,62,71)(H,63,76)(H,64,78)(H,65,77)(H,66,75)(H,67,73)/t28-,29+,35-,36-,37?,38-,39-,40-,44-/m0/s1 |
| CAS Registry Number |
87096-84-2 |
| Estrutura Molecular |
|
| Densidade |
1.337g/cm3 |
| Ponto de ebulição |
1697.4°C at 760 mmHg |
| índice de refração |
1.613 |
| O ponto de inflamação |
980.3°C |
| Pressão de vapor |
0mmHg at 25°C |
| Símbolos de perigo |
|
| Códigos de risco |
|
| Descrição da Segurança |
|
|
